490 related articles for article (PubMed ID: 26210507)
1. Combating highly resistant emerging pathogen Mycobacterium abscessus and Mycobacterium tuberculosis with novel salicylanilide esters and carbamates.
Baranyai Z; Krátký M; Vinšová J; Szabó N; Senoner Z; Horváti K; Stolaříková J; Dávid S; Bősze S
Eur J Med Chem; 2015 Aug; 101():692-704. PubMed ID: 26210507
[TBL] [Abstract][Full Text] [Related]
2. Salicylanilide N-monosubstituted carbamates: Synthesis and in vitro antimicrobial activity.
Krátký M; Vinšová J
Bioorg Med Chem; 2016 Mar; 24(6):1322-30. PubMed ID: 26879856
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.
Krátký M; Volková M; Novotná E; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2014 Aug; 22(15):4073-82. PubMed ID: 24953953
[TBL] [Abstract][Full Text] [Related]
4. Salicylanilide carbamates: antitubercular agents active against multidrug-resistant Mycobacterium tuberculosis strains.
Férriz JM; Vávrová K; Kunc F; Imramovský A; Stolaríková J; Vavríková E; Vinsová J
Bioorg Med Chem; 2010 Feb; 18(3):1054-61. PubMed ID: 20060303
[TBL] [Abstract][Full Text] [Related]
5. Antimycobacterial activity of salicylanilide benzenesulfonates.
Krátký M; Vinšová J; Rodriguez NG; Stolaříková J
Molecules; 2012 Jan; 17(1):492-503. PubMed ID: 22222908
[TBL] [Abstract][Full Text] [Related]
6. Salicylanilide pyrazinoates inhibit in vitro multidrug-resistant Mycobacterium tuberculosis strains, atypical mycobacteria and isocitrate lyase.
Krátký M; Vinšová J; Novotná E; Stolaříková J
Eur J Pharm Sci; 2014 Mar; 53():1-9. PubMed ID: 24333643
[TBL] [Abstract][Full Text] [Related]
7. New amino acid esters of salicylanilides active against MDR-TB and other microbes.
Krátký M; Vinšová J; Buchta V; Horvati K; Bösze S; Stolaříková J
Eur J Med Chem; 2010 Dec; 45(12):6106-13. PubMed ID: 20937542
[TBL] [Abstract][Full Text] [Related]
8. Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Krátký M; Janďourek O; Baranyai Z; Novotná E; Stolaříková J; Bősze S; Vinšová J
Eur J Med Chem; 2019 Nov; 181():111578. PubMed ID: 31401536
[TBL] [Abstract][Full Text] [Related]
9. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Krátký M; Bősze S; Baranyai Z; Szabó I; Stolaříková J; Paraskevopoulos G; Vinšová J
Bioorg Med Chem; 2015 Feb; 23(4):868-75. PubMed ID: 25593095
[TBL] [Abstract][Full Text] [Related]
11. In vitro biological evaluation of new antimycobacterial salicylanilide-tuftsin conjugates.
Baranyai Z; Krátký M; Vosátka R; Szabó E; Senoner Z; Dávid S; Stolaříková J; Vinšová J; Bősze S
Eur J Med Chem; 2017 Jun; 133():152-173. PubMed ID: 28384546
[TBL] [Abstract][Full Text] [Related]
12. Salicylanilide acetates: synthesis and antibacterial evaluation.
Vinsova J; Imramovsky A; Buchta V; Ceckova M; Dolezal M; Staud F; Jampilek J; Kaustova J
Molecules; 2007 Jan; 12(1):1-12. PubMed ID: 17693949
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the structure and antimycobacterial activity of substituted salicylanilides.
Waisser K; Bures O; Holý P; Kunes J; Oswald R; Jirásková L; Pour M; Klimesová V; Kubicová L; Kaustová J
Arch Pharm (Weinheim); 2003 Mar; 336(1):53-71. PubMed ID: 12666254
[TBL] [Abstract][Full Text] [Related]
14. Salicylanilide derivatives block Mycobacterium tuberculosis through inhibition of isocitrate lyase and methionine aminopeptidase.
Krátký M; Vinšová J; Novotná E; Mandíková J; Wsól V; Trejtnar F; Ulmann V; Stolaříková J; Fernandes S; Bhat S; Liu JO
Tuberculosis (Edinb); 2012 Sep; 92(5):434-9. PubMed ID: 22765970
[TBL] [Abstract][Full Text] [Related]
15. Salicylanilide ester prodrugs as potential antimicrobial agents--a review.
Krátký M; Vinsová J
Curr Pharm Des; 2011; 17(32):3494-505. PubMed ID: 22074422
[TBL] [Abstract][Full Text] [Related]
16. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.
Paraskevopoulos G; Monteiro S; Vosátka R; Krátký M; Navrátilová L; Trejtnar F; Stolaříková J; Vinšová J
Bioorg Med Chem; 2017 Feb; 25(4):1524-1532. PubMed ID: 28126437
[TBL] [Abstract][Full Text] [Related]
17. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents.
Imramovský A; Vinsová J; Férriz JM; Buchta V; Jampílek J
Bioorg Med Chem Lett; 2009 Jan; 19(2):348-51. PubMed ID: 19081718
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates.
Krátký M; Vinšová J; Novotná E; Mandíková J; Trejtnar F; Stolaková J
Molecules; 2013 Mar; 18(4):3674-88. PubMed ID: 23529028
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial assessment of Salicylanilide benzoates including multidrug-resistant tuberculosis strains.
Krátký M; Vinšová J; Stolaříková J
Molecules; 2012 Oct; 17(11):12812-20. PubMed ID: 23114617
[TBL] [Abstract][Full Text] [Related]
20. Investigation of salicylanilide and 4-chlorophenol-based N-monosubstituted carbamates as potential inhibitors of acetyl- and butyrylcholinesterase.
Krátký M; Štěpánková Š; Vorčáková K; Vinšová J
Bioorg Chem; 2018 Oct; 80():668-673. PubMed ID: 30059892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
